Breaking News Instant updates and real-time market news.

2022-05-23 07:09:44 BLDR Builders FirstSource $60.85 / -1.83 (-2.92%) 07:09 05/23/22 05/23 07:09 05/23/22 07:09	Builders FirstSource releases inaugural CSR report Builders FirstSource announced that it has published its inaugural Corporate Social Responsibility, CSR, report. "At Builders FirstSource, we pride ourselves on using our scale and resources to build a more sustainable future for all of our stakeholders," said Dave Flitman, President and CEO of Builders FirstSource. "We are proud of our efforts on this front and are committed to doing even more going forward as part of our mission to be a responsible and trusted partner for our communities and planet. Our CSR report provides an overview of the actions we have taken to become a better corporate steward for all, and we are pleased to report on our progress in this regard for the first time. It's an honor to lead this incredible organization, and I am energized by the opportunities that exist to further strengthen our social impact."	25 May 14 Jun

2022-05-23 07:09:44

BLDR

Builders FirstSource

$60.85 / -1.83 (-2.92%)

07:09

05/23/22

05/23

07:09

05/23/22

07:09

Builders FirstSource releases inaugural CSR report

Builders FirstSource announced that it has published its inaugural Corporate Social Responsibility, CSR, report. "At Builders FirstSource, we pride ourselves on using our scale and resources to build a more sustainable future for all of our stakeholders," said Dave Flitman, President and CEO of Builders FirstSource. "We are proud of our efforts on this front and are committed to doing even more going forward as part of our mission to be a responsible and trusted partner for our communities and planet. Our CSR report provides an overview of the actions we have taken to become a better corporate steward for all, and we are pleased to report on our progress in this regard for the first time. It's an honor to lead this incredible organization, and I am energized by the opportunities that exist to further strengthen our social impact."

25
May
14
Jun

OTHER BREAKING NEWS FROM THE FLY

Recommendations	Inspirato price target lowered to $7 from $9 at Piper Sandler » 18:38 08/08/22 08/08 18:38 08/08/22 18:38 ISPO Inspirato $4.93 / -0.11 (-2.18%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options ISPO Inspirato $4.93 / -0.11 (-2.18%) 06/09/22 Inspirato announces Inspirato Select subscription 04/21/22 Tang Capital reports 5.0% passive stake in Inspirato 04/18/22 Inspirato announces 11 new luxury residences at 71 Wentworth 04/11/22 Inspirato announces 2023 luxury cruise program ISPO Inspirato $4.93 / -0.11 (-2.18%) 07/22/22 Cantor Fitzgerald Inspirato assumed with a Neutral at Cantor Fitzgerald 06/28/22 Stifel Inspirato price target lowered to $6 from $7 at Stifel 06/14/22 Oppenheimer Inspirato initiated with a Perform at Oppenheimer 05/20/22 Evercore ISI Inspirato initiated with an In Line at Evercore ISI ISPO Inspirato $4.93 / -0.11 (-2.18%) 07:34 Today Inspirato reports Q2 EPS (6c) vs (1c) last year 05/11/22 Inspirato sees FY22 revenue $350M-$360M, consensus $354.13M 05/11/22 Inspirato reports Q1 EPS (26c), consensus (47c) ISPO Inspirato $4.93 / -0.11 (-2.18%) 06/14/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/11/22 Fly Intel: After-Hours Movers 04/21/22 Fly Intel: After-Hours Movers 11:00 Today Inspirato - ISPO ISPO Inspirato $4.93 / -0.11 (-2.18%) 07/11/22 Largest borrow rate increases among liquid names 07/07/22 Largest borrow rate increases among liquid names 05/11/22 Inspirato options imply 7.9% move in share price post-earnings 05/11/22 Largest borrow rate increases among liquid names
Periodicals	BP begins drilling appraisal well in Texas, Reuters reports » 18:33 08/08/22 08/08 18:33 08/08/22 18:33 BP BP $30.17 / +0.515 (+1.74%) Jack Collins, finance… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options BP BP $30.17 / +0.515 (+1.74%) 07:56 Today Cenovus Energy acquiring 50% interest in Toledo refinery from BP 08/03/22 FleetCor extends BP relationship 08/02/22 BP bosts dividend 10%, announces further $3.5B share buyback 08/02/22 BP announces further $3.5B share buyback BP BP $30.17 / +0.515 (+1.74%) 14:08 Today Berenberg BP price target lowered to 500 GBp from 510 GBp at Berenberg 07/20/22 HSBC BP price target lowered to 430 GBp from 455 GBp at HSBC 07/19/22 Piper Sandler BP price target raised to $44 from $42 at Piper Sandler 07/15/22 JPMorgan BP price target raised to 530 GBp from 500 GBp at JPMorgan BP BP $30.17 / +0.515 (+1.74%) 08/02/22 BP reports Q2 EPS $2.61, consensus $2.13 05/03/22 BP reports Q1 EPS $1.92, consensus $1.35 BP BP $30.17 / +0.515 (+1.74%) 08/03/22 OPEC+ answers diplomatic efforts with 'minuscule' output hike, Bloomberg says 08/02/22 OPEC+ sees slightly smaller oil market surplus in 2022, Reuters reports 07/14/22 BP looking to make sustainable aviation fuel in Australia by 2025, Reuters says 07/06/22 OPEC Secretary-General Mohammad Barkindo dies, Bloomberg reports BP BP $30.17 / +0.515 (+1.74%) 08/02/22 What You Missed On Wall Street On Tuesday 08/02/22 What You Missed On Wall Street This Morning 07/14/22 What You Missed On Wall Street This Morning 07/01/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations BP BP $30.17 / +0.515 (+1.74%) 08/05/22 Unusually active option classes on open August 5th 08/04/22 BP call volume above normal and directionally bullish 08/02/22 Unusually active option classes on open August 2nd 07/05/22 Unusually active option classes on open July 5th
Hot Stocks	Oshkosh CEO: We have a record backlog » 18:25 08/08/22 08/08 18:25 08/08/22 18:25 OSK Oshkosh $83.99 / +0.76 (+0.91%) In an interview on… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly OSK Oshkosh $83.99 / +0.76 (+0.91%) 06/30/22 Oshkosh awarded $216.73M Army contract modification 06/13/22 Oshkosh completes acquisition of Maxi-Metal 05/06/22 Oshkosh to increase share repurchase authorization by 8M shares 05/06/22 Oshkosh announces FY25 targets ahead of investor day OSK Oshkosh $83.99 / +0.76 (+0.91%) 07/28/22 Baird Oshkosh price target lowered to $83 from $84 at Baird 07/26/22 Argus Argus starts Oshkosh at Hold on near-term inflation and supply chain challenges 07/26/22 Argus Oshkosh initiated with a Hold at Argus 07/13/22 Deutsche Bank Oshkosh price target lowered to $101 from $118 at Deutsche Bank OSK Oshkosh $83.99 / +0.76 (+0.91%) 07/28/22 Oshkosh reports Q2 EPS 41c, consensus 90c 04/28/22 Environmental groups, state AGs sue to block Postal Service truck order 04/27/22 Oshkosh lowers FY22 EPS view to $5-$6, consensus $6.22 04/27/22 Oshkosh reports Q1 EPS 24c, consensus 16c OSK Oshkosh $83.99 / +0.76 (+0.91%) 07/20/22 USPS now plans more electric delivery vehicles, Reuters says 05/12/22 House panel investigating USPS plan to acquire gas-powered trucks, WP says OSK Oshkosh $83.99 / +0.76 (+0.91%) 07/26/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/12/22 What You Missed On Wall Street On Thursday 02/15/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
Hot Stocks	Robinhood exec sells $1.18M in common stock » 18:22 08/08/22 08/08 18:22 08/08/22 18:22 HOOD Robinhood $10.68 / +0.29 (+2.79%) In a regulatory filing,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options HOOD Robinhood $10.68 / +0.29 (+2.79%) 08/04/22 Robinhood CEO says in 'great position as a stand-alone company' 08/04/22 SEC probing Robinhood compliance with short selling rules 08/02/22 Robinhood sees FY22 operating expenses $1.7B-$1.76B 08/02/22 Robinhood cuts 23% of workforce amid reduced customer activity HOOD Robinhood $10.68 / +0.29 (+2.79%) 08/04/22 Deutsche Bank Robinhood price target raised to $9 from $8 at Deutsche Bank 08/04/22 Mizuho Robinhood price target lowered to $13 from $14 at Mizuho 08/03/22 Piper Sandler Robinhood price target lowered to $10 from $11 at Piper Sandler 07/25/22 JPMorgan JPMorgan sees increased share dilution risk for Coinbase, Robinhood HOOD Robinhood $10.68 / +0.29 (+2.79%) 08/03/22 Notable companies reporting after market close 08/02/22 Robinhood reports Q2 EPS (34c), consensus (37c) 04/28/22 Robinhood reports Q1 EPS (45c), consensus (36c) 04/28/22 Notable companies reporting after market close HOOD Robinhood $10.68 / +0.29 (+2.79%) 07/20/22 Study finds Robinhood cause of phantom surge in Berkshire Hathaway, WSJ reports 06/27/22 Bankman-Fried says FTX not in active M&A talks with Robinhood, WSJ says 06/27/22 FTX deliberating about potential of deal to buy Robinhood, Bloomberg says 06/27/22 FTX deliberating about potential of deal to buy Robinhood, Bloomberg says HOOD Robinhood $10.68 / +0.29 (+2.79%) 08/05/22 Here's What You Missed in Crypto This Week 08/03/22 Fly Intel: After-Hours Movers 08/03/22 What You Missed On Wall Street On Wednesday 08/03/22 What You Missed On Wall Street This Morning HOOD Robinhood $10.68 / +0.29 (+2.79%) 10:25 Today Robinhood Markets call volume above normal and directionally bullish 08/05/22 Unusually active option classes on open August 5th 08/04/22 Robinhood Markets call volume above normal and directionally bullish 08/04/22 Unusually active option classes on open August 4th
Hot Stocks	Corvex Management discloses 5% stake in MDU Resources » 18:12 08/08/22 08/08 18:12 08/08/22 18:12 MDU MDU Resources $29.08 / -0.125 (-0.43%) Corvex Management… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings MDU MDU Resources $29.08 / -0.125 (-0.43%) 08/04/22 MDU Resources to separate Knife River via tax-free spinoff to shareholders 08/04/22 MDU Resources to separate Knife River to create two public companies MDU MDU Resources $29.08 / -0.125 (-0.43%) 08/05/22 BofA MDU Resources downgraded to Neutral from Buy at BofA MDU MDU Resources $29.08 / -0.125 (-0.43%) 08/04/22 MDU Resources now sees FY22 EPS $1.75-$1.90, consensus $2.01 08/04/22 MDU Resources reports Q2 EPS 35c, consensus 51c 05/04/22 MDU Resources backs FY22 EPS view $2.00-$2.15, consensus $2.05 05/04/22 MDU Resources reports Q1 EPS 16c, consensus 21c
Hot Stocks	Bright Scholar to change ratio of its ADSs » 18:02 08/08/22 08/08 18:02 08/08/22 18:02 BEDU Bright Scholar / + Bright Scholar Education… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News BEDU Bright Scholar / + 08/03/22 Bright Scholar completes redemption of remaining outstanding senior notes 04/29/22 Bright Scholar receives preliminary non-binding 'going private' proposal 04/01/22 Bright Scholar receives noncompliance letter from NYSE
Hot Stocks	Pzena Investment reports AUM as of July 31 at $47.2B vs. $45.0B as of June 30 18:00 08/08/22 08/08 18:00 08/08/22 18:00 PZN Pzena Investment $9.49 / + (+0.00%) ShowHide Related Items >><< Company News Earnings On The Fly PZN Pzena Investment $9.49 / + (+0.00%) 07/26/22 Pzena Investment to become private company 06/07/22 Pzena Investment reports AUM as of May 31 $50.7B 06/07/22 Pzena Investment reports AUM as of May 31 $50.7B 05/09/22 Pzena Investment reports preliminary AUM $49.5B at April 30 PZN Pzena Investment $9.49 / + (+0.00%) 04/19/22 Pzena Investment reports Q1 EPS 16c vs 24c YoY PZN Pzena Investment $9.49 / + (+0.00%) 07/26/22 Fly Intel: After-Hours Movers 04/19/22 Fly Intel: After-Hours Movers
Conference/Events	BridgeBio management to meet with BTIG » 17:55 08/08/22 08/08 17:55 08/08/22 17:55 BBIO BridgeBio $11.91 / +0.745 (+6.67%) In conjunction with the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events BBIO BridgeBio $11.91 / +0.745 (+6.67%) 08/04/22 BridgeBio sees expenses, cash burn declining meaningfully in Q3, Q4 07/26/22 BridgeBio announces interim results from Phase 2 trial of infigratinib 07/25/22 BridgeBio and Sentynl receive positive opinion from CHMP for Nulibry 07/25/22 BridgeBio, Sentynl receive positive CHMP opinion for NULIBRY BBIO BridgeBio $11.91 / +0.745 (+6.67%) 08/05/22 JPMorgan BridgeBio selloff on Alnylam readout overdone, says JPMorgan 07/26/22 Piper Sandler BioMarin competitor BridgeBio data falls short, says Piper Sandler 03/16/22 H.C. Wainwright BridgeBio price target lowered to $22 from $24 at H.C. Wainwright 03/11/22 JPMorgan BridgeBio price target lowered to $18 from $21 at JPMorgan BBIO BridgeBio $11.91 / +0.745 (+6.67%) 08/04/22 BridgeBio reports Q2 EPS (7c), consensus (92c) 05/05/22 BridgeBio reports Q1 EPS ($1.35), consensus ($1.11) 02/24/22 BridgeBio reports Q4 EPS ($1.01), consensus (87c) BBIO BridgeBio $11.91 / +0.745 (+6.67%) 05/12/22 Fly Intel: Pre-market Movers 00:00 Today Biotechnology Conference 18:30 Today BridgeBio
Hot Stocks	Opiant Pharmaceuticals receives additional BARDA funding for OPNT003 » 17:52 08/08/22 08/08 17:52 08/08/22 17:52 OPNT Opiant Pharmaceuticals $11.83 / +0.46 (+4.05%) Opiant Pharmaceuticals… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events OPNT Opiant Pharmaceuticals $11.83 / +0.46 (+4.05%) 06/08/22 Opiant expands collaboration with Aptar Pharma 06/01/22 Opiant begins rolling submission of NDA to FDA for opioid overdose treatment 05/13/22 Opiant Pharmaceuticals Inc trading resumes 05/13/22 Opiant Pharmaceuticals Inc trading halted, volatility trading pause OPNT Opiant Pharmaceuticals $11.83 / +0.46 (+4.05%) 04/28/22 Northland Northland sees 'major buying pportunity' as Opiant wraps OPNT003 clinical work 12/08/21 Oppenheimer Opiant Pharmaceuticals initiated with an Outperform at Oppenheimer OPNT Opiant Pharmaceuticals $11.83 / +0.46 (+4.05%) 05/10/22 Opiant Pharmaceuticals reports Q1 EPS ($2.43), consensus (91c) 03/15/22 Opiant Pharmaceuticals reports Q4 EPS 11c, consensus (1c) 08/11/22 Opiant Pharmaceuticals - OPNT
Hot Stocks	Enthusiast Gaming updates senior management team, names John Albright chairman » 17:51 08/08/22 08/08 17:51 08/08/22 17:51 EGLX Enthusiast Gaming $1.94 / +0.05 (+2.65%) Enthusiast Gaming… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research EGLX Enthusiast Gaming $1.94 / +0.05 (+2.65%) 07/07/22 Enthusiast Gaming to initiate search for new CEO following role switch 07/07/22 Enthusiast Gaming announces two nominees from Greywood Investments to join board 06/30/22 Enthusiast Gaming issued letter to shareholders 06/27/22 Greywood Investments issues letter to Enthusiast Gaming shareholders EGLX Enthusiast Gaming $1.94 / +0.05 (+2.65%) 07/19/22 B. Riley Enthusiast Gaming price target lowered to C$7.25 from C$11.50 at B. Riley 05/17/22 RBC Capital Enthusiast Gaming price target raised to C$8 from C$7 at RBC Capital 03/29/22 Scotiabank Enthusiast Gaming price target lowered to C$8 from C$8.25 at Scotiabank 03/24/22 Scotiabank Enthusiast Gaming price target lowered to C$8.25 from C$9.75 at Scotiabank

Periodicals	U.S. judge skeptical of Ben & Jerry's claims against Unilever, Reuters says » 17:49 08/08/22 08/08 17:49 08/08/22 17:49 UL Unilever $48.41 / +0.34 (+0.71%) , UN Use symbol UL $60.50 / + (+0.00%) U.S. District Judge… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events UL UN UL Unilever $48.41 / +0.34 (+0.71%) 07/20/22 Unilever Food Solutions U.S. recalls Knorr Professional Soup du Jour soup mix 06/29/22 Unilever sells Ben & Jerry's business interests in Israel to current licensee 06/29/22 Unilever expands partnership with Numerator 06/16/22 Unilever, Genomatica launch $120M JV for alternative to palm oil ingredients UN Use symbol UL $60.50 / + (+0.00%) 07/20/22 Unilever Food Solutions U.S. recalls Knorr Professional Soup du Jour soup mix 05/11/22 AXA, Unilever, Tikehau Capital sign MOU to create impact fund UL UN UL Unilever $48.41 / +0.34 (+0.71%) 07/27/22 DZ Bank Unilever downgraded to Hold from Buy at DZ Bank 07/26/22 Deutsche Bank Unilever upgraded at Deutsche Bank as commodity headwinds flip to tailwinds 07/26/22 Deutsche Bank Unilever upgraded to Buy from Hold at Deutsche Bank 07/22/22 Bernstein Unilever upgraded to Outperform from Market Perform at Bernstein UN Use symbol UL $60.50 / + (+0.00%) 01/17/22 Bernstein Unilever downgraded to Underperform from Market Perform at Bernstein 01/17/22 Barclays Unilever downgraded to Equal Weight from Overweight at Barclays 01/10/22 Citi Unilever resumed with a Buy at Citi 11/01/21 Bernstein Unilever upgraded to Market Perform from Underperform at Bernstein UL UL Unilever $48.41 / +0.34 (+0.71%) 07/26/22 Unilever raises 2022 sales growth view 07/26/22 Unilever reports Q1 EPS EUR1.34, up 1% y/y UL UN UL Unilever $48.41 / +0.34 (+0.71%) 08/03/22 Unilever ceases paying Ben & Jerry's independent board members, FT reports 08/01/22 Ben & Jerry's talks with Unilever over Israel unit sale break down, Reuters says 07/26/22 Unilever raised prices 11% in Q2, FT reports 07/05/22 Ben & Jerry's sues Unilever to block Israeli business sale, Reuters reports UN Use symbol UL $60.50 / + (+0.00%) 08/01/22 Ben & Jerry's talks with Unilever over Israel unit sale break down, Reuters says UL UL Unilever $48.41 / +0.34 (+0.71%) 07/22/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/31/22 What You Missed On Wall Street On Tuesday 05/31/22 What You Missed On Wall Street This Morning 05/31/22 Fly Intel: Pre-market Movers 09/19/22 Groceryshop
Hot Stocks	Clover Health CEO Vivek Garipalli to switch roles, Andrew Toy to succeed » 17:47 08/08/22 08/08 17:47 08/08/22 17:47 CLOV Clover Health $3.40 / +0.14 (+4.30%) , GOOG Alphabet $118.17 / -0.11 (-0.09%) , GOOGL Alphabet $117.32 / -0.17 (-0.14%) Clover Health (CLOV)… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options CLOV GOOG GOOGL CLOV Clover Health $3.40 / +0.14 (+4.30%) 07/14/22 Clover Health announces planned medicare edvantage expansion for 2023 06/24/22 Clover Health is set to join the Russell 3000 Index 05/25/22 Clover Health appoints Scott Leffler as CFO 03/14/22 Clover Health appoints Joseph Martin as general counsel GOOG Alphabet $118.17 / -0.11 (-0.09%) 08/02/22 Mandiant to not provide guidance due to pending transaction with Google 08/02/22 Thryv and Google team to streamline communication for small businesses 07/31/22 Fly Intel: Top five weekend stock stories 07/29/22 Google says Stadia game streaming service not shutting down GOOGL Alphabet $117.32 / -0.17 (-0.14%) 08/02/22 Mandiant to not provide guidance due to pending transaction with Google 07/31/22 Fly Intel: Top five weekend stock stories 07/29/22 Google says Stadia game streaming service not shutting down 07/28/22 Google updates Play Store policies around intrusive advertisements CLOV GOOG GOOGL CLOV Clover Health $3.40 / +0.14 (+4.30%) 02/24/22 Canaccord Clover Health price target raised to $7 from $6 at Canaccord 02/17/22 Citi Citi opens 'negative catalyst watches' in health care services 02/02/22 Cowen Clover Health upgraded to Market Perform from Underperform at Cowen 01/19/22 SVB Leerink Clover Health initiated with a Market Perform at SVB Leerink GOOG Alphabet $118.17 / -0.11 (-0.09%) 08/03/22 Tigress Financial Alphabet price target raised to $186 from $183 at Tigress Financial 07/27/22 Truist Chrome cookie phase-out delay positive for Criteo, says Truist 07/27/22 KeyBanc Google's cookie phase-out delay not surprising, says KeyBanc 07/27/22 RBC Capital Google cookie phase-out delay adds another year of uncertainty, says RBC Capital GOOGL Alphabet $117.32 / -0.17 (-0.14%) 08/03/22 Tigress Financial Alphabet price target raised to $186 from $183 at Tigress Financial 07/27/22 Truist Chrome cookie phase-out delay positive for Criteo, says Truist 07/27/22 KeyBanc Google's cookie phase-out delay not surprising, says KeyBanc 07/27/22 RBC Capital Google cookie phase-out delay adds another year of uncertainty, says RBC Capital CLOV GOOG GOOGL CLOV Clover Health $3.40 / +0.14 (+4.30%) 17:16 Today Clover Health reports Q2 revenue $846.7M, consensus $814.62M 05/09/22 Clover Health reaffirms FY22 revenue view $3.0B-$3.4B, consensus $3.24B 05/09/22 Clover Health reports Q1 revenue $874.4M, consensus $787.41M 02/23/22 Clover Health sees FY22 revenue $3.0B-$3.4B, consensus $2.62B GOOG Alphabet $118.17 / -0.11 (-0.09%) 07/26/22 Alphabet reports Q2 EPS $1.21, consensus $1.30 07/26/22 Notable companies reporting after market close 04/26/22 Alphabet reports Q1 EPS $24.62, consensus $25.96 04/26/22 Notable companies reporting after market close GOOGL Alphabet $117.32 / -0.17 (-0.14%) 07/26/22 Alphabet reports Q2 EPS $1.21, consensus $1.30 07/26/22 Notable companies reporting after market close 04/26/22 Alphabet reports Q1 EPS $24.62, consensus $25.96 04/26/22 Notable companies reporting after market close 18 Nov GOOG GOOGL GOOG Alphabet $118.17 / -0.11 (-0.09%) 08:16 Today Google files two more patent lawsuits against Sonos, Bloomberg Law reports 08/04/22 EU antitrust enforcers to investigate Google Play Store rules, Politico reports 08/02/22 Rumble allowed to proceed with antitrust suit against Google, Verge reports 08/01/22 Amazon hires senior congressional aide to fight antitrust bill, Bloomberg says GOOGL Alphabet $117.32 / -0.17 (-0.14%) 08:16 Today Google files two more patent lawsuits against Sonos, Bloomberg Law reports 08/04/22 EU antitrust enforcers to investigate Google Play Store rules, Politico reports 08/02/22 Rumble allowed to proceed with antitrust suit against Google, Verge reports 08/01/22 Amazon hires senior congressional aide to fight antitrust bill, Bloomberg says CLOV GOOG GOOGL CLOV Clover Health $3.40 / +0.14 (+4.30%) 05/10/22 Fly Intel: Pre-market Movers 05/09/22 Fly Intel: After-Hours Movers 02/24/22 What You Missed On Wall Street On Thursday 02/24/22 What You Missed On Wall Street This Morning GOOG Alphabet $118.17 / -0.11 (-0.09%) 16:46 Today What You Missed On Wall Street On Monday 12:12 Today What You Missed On Wall Street This Morning 08/04/22 What You Missed On Wall Street This Morning 08/03/22 #SocialStocks: Five-day trial between Twitter and Elon Musk set for October 17 GOOGL Alphabet $117.32 / -0.17 (-0.14%) 16:46 Today What You Missed On Wall Street On Monday 12:12 Today What You Missed On Wall Street This Morning 08/04/22 What You Missed On Wall Street This Morning 08/03/22 #SocialStocks: Five-day trial between Twitter and Elon Musk set for October 17 17:00 Today Clover Health - CLOV CLOV GOOG GOOGL CLOV Clover Health $3.40 / +0.14 (+4.30%) 13:34 Today Clover Health options imply 12.4% move in share price post-earnings 07/18/22 Unusually active option classes on open July 18th 06/27/22 Unusually active option classes on open June 27th 06/21/22 Unusually active option classes on open June 21st GOOG Alphabet $118.17 / -0.11 (-0.09%) 07/26/22 Alphabet options imply 6.1% move in share price post-earnings 07/25/22 Unusually active option classes on open July 25th 07/25/22 Alphabet put buyer realizes 47% same-day gains 07/22/22 Unusually active option classes on open July 22nd GOOGL Alphabet $117.32 / -0.17 (-0.14%) 07/27/22 Notable open interest changes for July 27th 07/26/22 Alphabet Class A options imply 6.1% move in share price post-earnings 07/25/22 Unusually active option classes on open July 25th 07/22/22 Unusually active option classes on open July 22nd
Hot Stocks	Horizon Global announces review of strategic alternatives » 17:46 08/08/22 08/08 17:46 08/08/22 17:46 HZN Horizon Global $1.38 / +0.035 (+2.60%) Horizon Global announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Events HZN Horizon Global $1.38 / +0.035 (+2.60%) 07/29/22 Horizon Global addresses NYSE continued listing standards 06/29/22 Horizon Global appoints Jian James Zhou as CFO 06/08/22 Horizon Global and Continental settle patent dispute 02/14/22 Horizon Global rises 10.6% 08/09/22 Horizon Global - HZN
Earnings	Cara Therapeutics reports Q2 EPS (8c), consensus (25c) » 17:43 08/08/22 08/08 17:43 08/08/22 17:43 CARA Cara Therapeutics $11.50 / +0.215 (+1.91%) Reports Q2 revenue $23M,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events CARA Cara Therapeutics $11.50 / +0.215 (+1.91%) 06/30/22 Cara Therapeutics announces results from Phase 2 trial of difelikefalin 06/06/22 Amarin CFO Michael Kalb resigns, Tom Reilly to succeed 06/03/22 Cara Therapeutics CFO Thomas Reilly resigns, Richard Makara named interim CFO 04/28/22 Vifor Fresenius, Cara announces European Commission authorization for Kapruvia CARA Cara Therapeutics $11.50 / +0.215 (+1.91%) 05/10/22 H.C. Wainwright H.C. Wainwright sees 'major valuation disconnect' at Cara Therapeutics 03/14/22 Canaccord Cara Therapeutics price target lowered to $29 from $33 at Canaccord 03/08/22 JPMorgan Cara Therapeutics upgraded to Overweight from Neutral at JPMorgan 11/01/21 Canaccord Cara Therapeutics assumed with a Buy at Canaccord CARA Cara Therapeutics $11.50 / +0.215 (+1.91%) 05/09/22 Cara Therapeutics reports Q1 EPS (52c), consensus (54c) 03/01/22 Cara Therapeutics reports Q4 EPS (63c), consensus (52c) 00:00 Today 42nd Annual Global I Growth Conference 16:30 Today Cara Therapeutics - CARA
Earnings	Chimerix reports Q2 EPS (27c), consensus (24c) » 17:36 08/08/22 08/08 17:36 08/08/22 17:36 CMRX Chimerix $2.36 / -0.325 (-12.13%) Reports Q2 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events CMRX Chimerix $2.36 / -0.325 (-12.13%) 07:22 Today Chimerix appoints Jordan as VP, Regulatory Affairs 08/04/22 Siga, Chimerix rallyafter WaPo report of monkeypox emergency declaration 06/24/22 Chimerix announces $25.3M TEMBEXA procurement agreement 06/23/22 Chimerix announces $9.3M TEMBEXA procurement agreement CMRX Chimerix $2.36 / -0.325 (-12.13%) 05/20/22 Benchmark Benchmark says Emergent, Siga, Chimerix strength attributable to monkeypox scare 05/16/22 H.C. Wainwright Chimerix price target lowered to $11 from $24 at H.C. Wainwright 12/22/21 H.C. Wainwright Chimerix price target raised to $24 from $21 at H.C. Wainwright 11/22/21 H.C. Wainwright Chimerix price target raised to $21 from $19 at H.C. Wainwright CMRX Chimerix $2.36 / -0.325 (-12.13%) 05/16/22 Chimerix reports Q1 EPS (28c), consensus (33c) 03/01/22 Chimerix reports Q4 EPS (45c), consensus (17c) 15 Sep CMRX Chimerix $2.36 / -0.325 (-12.13%) 08/04/22 Biden to declare monkeypox public health emergency, Washington Post says 07/25/22 WHO declares monkeypox outbreak global health emergency, CNBC reports CMRX Chimerix $2.36 / -0.325 (-12.13%) 08/04/22 What You Missed On Wall Street On Thursday 07/25/22 These vaccine makers are jumping after monkeypox declared global emergency 05/27/22 As Monkeypox cases rise, so do shares of Siga 05/16/22 What You Missed On Wall Street On Monday 08/09/22 Wedbush PacGrow Healthcare Virtual Conference 16:30 Today Chimerix - CMRX
Hot Stocks	Ur-Energy signs agreement with U.S. nuclear utility » 17:35 08/08/22 08/08 17:35 08/08/22 17:35 URG Ur-Energy $1.18 / -0.01 (-0.84%) Ur-Energy announce that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Periodicals URG Ur-Energy $1.18 / -0.01 (-0.84%) 11/02/21 Alliance Global Partners Ur-Energy price target raised to $2.50 from $2.20 at Alliance Global Partners URG Ur-Energy $1.18 / -0.01 (-0.84%) 04/18/22 Energy Department set to announce $6B nuclear plant lifeline, Bloomberg says
Earnings	Mesa Air reports Q3 EPS (28c), consensus (22c) » 17:34 08/08/22 08/08 17:34 08/08/22 17:34 MESA Mesa Air $2.66 / +0.135 (+5.35%) Reports Q3 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events MESA Mesa Air $2.66 / +0.135 (+5.35%) 06/08/22 Mesa Air announces enhanced United Aviate partnership 04/22/22 Mesa Air appoints Amy Krallman as VP, human resources 03/01/22 Mesa Air appoints Christian Daoud as VP, maintenance and technical operations MESA Mesa Air $2.66 / +0.135 (+5.35%) 05/11/22 Deutsche Bank Mesa Air price target lowered to $3 from $5.50 at Deutsche Bank 02/04/22 Raymond James Mesa Air downgraded to Market Perform from Outperform at Raymond James 02/04/22 Raymond James Mesa Air downgraded to Market Perform from Outperform at Raymond James 01/07/22 BofA Mesa Air downgraded to Neutral from Buy at BofA MESA Mesa Air $2.66 / +0.135 (+5.35%) 05/09/22 Mesa Air reports Q2 EPS ( 29c), consensus (31c) 02/09/22 Mesa Air reports Q EPS (26c), consensus (12c) 16:30 Today Mesa Air - MESA
Hot Stocks	National Healthcare announces $25M stock repurchase authorization » 17:31 08/08/22 08/08 17:31 08/08/22 17:31 NHC National Healthcare $69.31 / +1.14 (+1.67%) National HealthCare… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Earnings NHC National Healthcare $69.31 / +1.14 (+1.67%) 05/05/22 National Healthcare raises quarterly dividend by 3.6% to 57c per share NHC National Healthcare $69.31 / +1.14 (+1.67%) 02/18/22 National Healthcare reports Q4 adjusted EPS $1.02 vs. 90c last year
Hot Stocks	CorMedix receives CRL from FDA saying that DefenCath NDA cannot be approved » 17:31 08/08/22 08/08 17:31 08/08/22 17:31 CRMD CorMedix $7.50 / +0.39 (+5.49%) CorMedix announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Earnings On The Fly Events CRMD CorMedix $7.50 / +0.39 (+5.49%) 05/12/22 CorMedix believes it has sufficient resources to fund through 1H of 2023 05/12/22 CorMedix announces leadership updates, operational changes 04/07/22 CorMedix announces SAB to support commercialization, pipeline development 03/28/22 CorMedix announces FDA acceptance of resubmission of NDA for DefenCath CRMD CorMedix $7.50 / +0.39 (+5.49%) 05/12/22 CorMedix reports Q1 EPS (18c), consensus (22c) 03/29/22 CorMedix reports Q4 EPS (20c), consensus (23c) CRMD CorMedix $7.50 / +0.39 (+5.49%) 03/29/22 Fly Intel: After-Hours Movers 08/11/22 CorMedix - CRMD
Syndicate	Cyteir Therapeutics files $300M mixed securities shelf 17:30 08/08/22 08/08 17:30 08/08/22 17:30 CYT Cyteir Therapeutics $2.58 / +0.09 (+3.61%) ShowHide Related Items >><< Company News Street Research Earnings Events CYT Cyteir Therapeutics $2.58 / +0.09 (+3.61%) 16:08 Today Cyteir Therapeutics expects cash to fund operations into second half of 2024 06/05/22 Cyteir Therapeutics presents CYT-0851 Phase 1 dose escalation results 04/25/22 Cyteir Therapeutics appoints Adam Veness as general counsel CYT Cyteir Therapeutics $2.58 / +0.09 (+3.61%) 03/17/22 Wedbush Cyteir Therapeutics price target lowered to $30 from $40 at Wedbush 02/07/22 Northland Cyteir Therapeutics initiated with an Outperform at Northland CYT Cyteir Therapeutics $2.58 / +0.09 (+3.61%) 16:08 Today Cyteir Therapeutics reports Q2 EPS (34c), consensus (44c) 05/05/22 Cyteir Therapeutics reports Q1 EPS (40c), consensus (39c) 03/16/22 Cyteir Therapeutics reports Q4 EPS (34c), consensus (39c) 00:00 Today Biotechnology Conference 08/09/22 Wedbush PacGrow Healthcare Virtual Conference

Syndicate	Biolase files to sell 1.41M shares of common stock for holders 17:30 08/08/22 08/08 17:30 08/08/22 17:30 BIOL Biolase $5.40 / +0.12 (+2.27%) ShowHide Related Items >><< Company News Street Research Earnings Events BIOL Biolase $5.40 / +0.12 (+2.27%) 07/25/22 Biolase receives five new United States patents, seven new foreign patents 07/13/22 Biolase announces pilot program with Einstein Healthcare Network's residency 07/07/22 Biolase promotes Jennifer Bright to CFO, Steven Sandor to COO 07/05/22 Biolase announces partnership with TeamSmile BIOL Biolase $5.40 / +0.12 (+2.27%) 05/20/22 Lake Street Biolase initiated with a Buy at Lake Street 08/19/21 Ascendiant Biolase price target raised to $3 from $2 at Ascendiant BIOL Biolase $5.40 / +0.12 (+2.27%) 05/12/22 Biolase sees Q2 revenue above $10.5M, consensus $10.2M 05/12/22 Biolase reports Q1 EPS (77c), consensus (68c) 08/11/22 Biolase - BIOL
Syndicate	CinCor Pharma files to sell 6M shares of common stock, pre-funded warrants » 17:29 08/08/22 08/08 17:29 08/08/22 17:29 CINC CinCor Pharma $34.96 / +11.46 (+48.77%) Goldman Sachs & Co.,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options CINC CinCor Pharma $34.96 / +11.46 (+48.77%) 07:24 Today CinCor Pharma announces data for Phase 2 BrigHtn trial evaluating baxdrostat 07:21 Today CinCor Pharma announces upcoming milestones 07/26/22 CinCor Pharma announces last patient randomized in Phase 2 HALO trial 06/01/22 CinCor Pharma doses first patient in Phase 2 figHTN-CKD trial CINC CinCor Pharma $34.96 / +11.46 (+48.77%) 14:35 Today Oppenheimer CinCor Pharma price target raised to $60 from $35 at Oppenheimer 07/21/22 Oppenheimer CinCor Pharma price target raised to $35 from $30 at Oppenheimer 02/01/22 Oppenheimer CinCor Pharma initiated with an Outperform at Oppenheimer 02/01/22 Evercore ISI CinCor Pharma initiated with an Outperform at Evercore ISI CINC CinCor Pharma $34.96 / +11.46 (+48.77%) 07:20 Today CinCor Pharma reports Q2 EPS (56c), consensus (50c) 05/10/22 CinCor Pharma reports Q1 EPS (50c), consensus (50c) 03/22/22 CinCor Pharma reports Q4 EPS ($15.71) vs. ($4.65) last year 07 Jan CINC CinCor Pharma $34.96 / +11.46 (+48.77%) 16:46 Today What You Missed On Wall Street On Monday 12:12 Today What You Missed On Wall Street This Morning 03/26/22 Opening Day: AN2 Therapeutics rises in public debut after upsized IPO 08:30 Today CinCor Pharma - CINC CINC CinCor Pharma $34.96 / +11.46 (+48.77%) 07/13/22 Two new option listings on July 13th
Earnings	Primoris reports Q2 adjusted EPS 48c, two estimates 59c » 17:29 08/08/22 08/08 17:29 08/08/22 17:29 PRIM Primoris $22.52 / +0.095 (+0.42%) Reports Q2 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events PRIM Primoris $22.52 / +0.095 (+0.42%) 07/05/22 Primoris awarded contract at over $170M 06/27/22 Primoris enter agreement to acquire PLH in all-cash transaction valued at $470M 06/23/22 Primoris awarded $260M solar project 05/06/22 Primoris awarded $130M solar project PRIM Primoris $22.52 / +0.095 (+0.42%) 11/10/21 Goldman Sachs Goldman downgrades Primoris to Sell on 'bottom quintile' growth 11/10/21 Goldman Sachs Primoris downgraded to Sell from Neutral at Goldman Sachs PRIM Primoris $22.52 / +0.095 (+0.42%) 05/09/22 Primoris raises FY22 adjusted EPS view to $2.49-$2.69 from $2.39-$2.59 05/09/22 Primoris reports Q1 adjusted EPS 1c, consensus 9c 02/28/22 Primoris sees FY22 EPS $2.39-$2.59, consensus $2.50 02/28/22 Primoris reports Q4 EPS 63c, consensus 56c 08/09/22 Primoris - PRIM
Syndicate	Merchants Bancorp files $500M mixed securities shelf 17:27 08/08/22 08/08 17:27 08/08/22 17:27 MBIN Merchants Bancorp $27.72 / +0.445 (+1.63%) ShowHide Related Items >><< Company News Earnings MBIN Merchants Bancorp $27.72 / +0.445 (+1.63%) 02/17/22 Merchants Bancorp raises quarterly dividend 17% to 7c from 6c per share MBIN Merchants Bancorp $27.72 / +0.445 (+1.63%) 04/28/22 Merchants Bancorp reports Q1 EPS $1.02, consensus $1.00
Earnings	Freshpet backs FY22 revenue view of at least $575M, consensus $582.72M » 17:27 08/08/22 08/08 17:27 08/08/22 17:27 FRPT Freshpet $56.39 / +1.895 (+3.48%) Sees FY22 adjusted EBITDA… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events FRPT Freshpet $56.39 / +1.895 (+3.48%) 06/22/22 Freshpet recalls select product due to potential Salmonella contamination FRPT Freshpet $56.39 / +1.895 (+3.48%) 05/20/22 Atlantic Equities Atlantic Equities sees more volatility for Freshpet, downgrades shares 05/20/22 Atlantic Equities Freshpet downgraded to Neutral from Overweight at Atlantic Equities 05/03/22 Cowen Freshpet price target lowered to $163 from $181 at Cowen 05/03/22 Oppenheimer Freshpet price target lowered to $110 from $120 at Oppenheimer FRPT Freshpet $56.39 / +1.895 (+3.48%) 17:25 Today Freshpet reports Q2 EPS (45c), consensus (14c) 05/02/22 Freshpet backs FY22 revenue view at least $575M, consensus $576.99M 05/02/22 Freshpet reports Q1 EPS (40c), consensus (39c) 02/28/22 Freshpet sees FY22 revenue $575M, consensus $562.4M 04 May FRPT Freshpet $56.39 / +1.895 (+3.48%) 05/20/22 Proven algorithm says sell these stocks now 05/20/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/13/22 Short Report: Upstart shorts take profits as stock craters on guidance cut 05/13/22 Proven algorithm says sell these stocks now 16:30 Today Freshpet - FRPT 08/11/22 Freshpet

Events

Earnings calls, analyst events, roadshows and more

YALA
Today at 20:00

Yalla - YALA Conference Calls
ORGN ...
Tomorrow at 00:00

SMID Cap Ideas Virtual Conference Conferences

Virtual Conference
Tomorrow at 00:00

10th Annual Internet & Media Bus Tour Conferences

San Francisco, CA
SI ...
Tomorrow at 00:00

42nd Annual Global I Growth Conference Conferences

Boston, MA
HLMN ...
Tomorrow at 00:00

Building & Building Products Conference Conferences

New York, NY
Tomorrow at 00:00

Biotechnology Conference Conferences

New York, NY
STEP
Tomorrow at 00:00

Financial Services Conference Conferences

Kohler, WI
IMUX ...
Tomorrow at 00:00

Wedbush PacGrow Healthcare Virtual Conference Conferences

Virtual Conference
F ...
Tomorrow at 00:00

Auto Conference Conferences

New York, NY
CTS ...
Tomorrow at 00:00

Jefferies Industrial Conerence Conferences

New York, NY

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	NUZE X NUZE NuZee Spot Secondary Managers: Maxim Priced at: $0.82 4.2M Shares
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	AYTU X AYTU Aytu BioPharma Spot Secondary Managers: Cantor Fitzgerald & Canaccord $0.59 MDNA X MDNA Medicenna Therapeutics Spot Secondary Managers: Guggenheim, Bloom Burton Securities $1.45-1.55 PFLT X PFLT PennantPark Floating Rate Spot Secondary Managers: Morgan Stanley, Goldman Sachs, JPMorgan, Keefe Bruyette, RBC Capital & Truist $12.40-12.70
Tues	KRTX X KRTX Karuna Therapeutics Secondary Managers: Goldman Sachs & JPMorgan, Jefferies $241.19 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	FRZA X FRZA Forza X1 IPO Managers: ThinkEquity $5.00 3M Shares PTLO X PTLO Portillo's Secondary Managers: Jefferies & Morgan Stanley, BofA, Piper Sandler $28.44 8M Shares SOVO X SOVO Sovos Brands Secondary Managers: JPMorgan & Goldman Sachs, BofA, Credit Suisse, Barclays, UBS, Cowen, Piper Sandler, Stifel, William Blair, Telsey Advisory, Drexel Hamilton, Loop Capital $16.01 8.5M Shares
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Builders FirstSource releases inaugural CSR report

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access